Laurensse E - Search Results

1

DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.

Schwartsmann G, Peters GJ, Laurensse E, de Waal FC, Loonen AH, Leyva A, Pinedo HM. Schwartsmann G, et al. Among authors: laurensse e. Biochem Pharmacol. 1988 Sep 1;37(17):3257-66. doi: 10.1016/0006-2952(88)90636-3. Biochem Pharmacol. 1988. PMID: 2840910

2

Retention of in vivo antipyrimidine effects of Brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancer.

Peters GJ, Nadal JC, Laurensse EJ, de Kant E, Pinedo HM. Peters GJ, et al. Among authors: laurensse ej. Biochem Pharmacol. 1990 Jan 1;39(1):135-44. doi: 10.1016/0006-2952(90)90657-7. Biochem Pharmacol. 1990. PMID: 2153375

3

In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.

Peters GJ, Schwartsmann G, Nadal JC, Laurensse EJ, van Groeningen CJ, van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Among authors: laurensse ej. Cancer Res. 1990 Aug 1;50(15):4644-9. Cancer Res. 1990. PMID: 2164443

4

Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Peters GJ, van Groeningen CJ, Laurensse EJ, Lankelma J, Leyva A, Pinedo HM. Peters GJ, et al. Among authors: laurensse ej. Cancer Chemother Pharmacol. 1987;20(2):101-8. doi: 10.1007/BF00253962. Cancer Chemother Pharmacol. 1987. PMID: 3664929

5

The relation between inhibition of cell growth and of dihydroorotic acid dehydrogenase by brequinar sodium.

de Kant E, Pinedo HM, Laurensse E, Peters GJ. de Kant E, et al. Among authors: laurensse e. Cancer Lett. 1989 Jul 15;46(2):123-7. doi: 10.1016/0304-3835(89)90019-0. Cancer Lett. 1989. PMID: 2546667

6

The relationship between dihydroorotic acid dehydrogenase and in vitro and in vivo cytostatic effects of brequinar sodium (DUP-785; NSC 368390).

Peters GJ, Laurensse E, de Kant E, Nadal JC, Pinedo HM. Peters GJ, et al. Among authors: laurensse e. Adv Exp Med Biol. 1989;253B:375-82. doi: 10.1007/978-1-4684-5676-9_55. Adv Exp Med Biol. 1989. PMID: 2558540 No abstract available.

7

Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Peters GJ, Sharma SL, Laurensse E, Pinedo HM. Peters GJ, et al. Among authors: laurensse e. Invest New Drugs. 1987;5(3):235-44. doi: 10.1007/BF00175293. Invest New Drugs. 1987. PMID: 2822596

8

Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity.

Peters GJ, Laurensse E, Leyva A, Pinedo HM. Peters GJ, et al. Among authors: laurensse e. Eur J Cancer Clin Oncol. 1987 Dec;23(12):1869-81. doi: 10.1016/0277-5379(87)90053-8. Eur J Cancer Clin Oncol. 1987. PMID: 3436351

9

A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa.

Peters GJ, van Groeningen CJ, Laurensse EJ, Pinedo HM. Peters GJ, et al. Among authors: laurensse ej. Cancer. 1991 Nov 1;68(9):1903-9. doi: 10.1002/1097-0142(19911101)68:9<1903::aid-cncr2820680910>3.0.co;2-9. Cancer. 1991. PMID: 1717130

10

Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: enzyme activity and inhibition by 5-fluoro-2'-deoxy-uridine-5'-monophosphate.

Peters GJ, van Groeningen CJ, Laurensse EJ, Pinedo HM. Peters GJ, et al. Among authors: laurensse ej. Eur J Cancer. 1991;27(3):263-7. doi: 10.1016/0277-5379(91)90512-c. Eur J Cancer. 1991. PMID: 1827310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters